Publicacións en colaboración con investigadores/as de Leiden University (14)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

    Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197

2020

  1. A consensus on the diagnosis and treatment of acromegaly comorbidities: An update

    Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946

2019

  1. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

    Nature Communications, Vol. 10, Núm. 1

  2. STATegra, a comprehensive multi-omics dataset of B-cell differentiation in mouse

    Scientific data, Vol. 6, Núm. 1, pp. 256

2018

  1. Origins and genetic legacies of the Caribbean Taino

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 10, pp. 2341-2346

2015

  1. Genome-wide ancestry of 17th-century enslaved Africans from the Caribbean

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 12, pp. 3669-3673

2013

  1. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: Systematic literature review and meta-analysis informing a consensus statement

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 583-589

  2. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492

2010

  1. Erratum to A genome-wide association study identifies a common variant near the GPR22 gene as a new locus involved in prevalence and progression of osteoarthritis [Bone, 44S2 (2009) S224]

    Bone

2008

  1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373

  2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364

2005

  1. Preparation of 13C4-6-methyl anthranilic ester via a Diels-Alder-type process. An experimental and theoretical study to characterize an unexpected isotope exchange

    Organic Letters, Vol. 7, Núm. 17, pp. 3773-3776